Thermo Fisher Scientific
TMO · NYSE
About TMO
- Employees
- 125,000
- Headquarters
- Waltham, Massachusetts
- Listed
- Aug 27, 1980
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Website
- corporate.thermofisher.com
TMO key statistics
- Market cap
- 251.20B
- Price-earnings ratio
- 36.55
- Dividend yield
- 0.26%
- Average volume
- 2.23M
- Volume
- 2.58M
- Open price
- $680.17
- High today
- $693.37
- Low today
- $679.32
- 52 Week high
- $704.00
- 52 Week low
- $435.27
Thermo Fisher Scientific (TMO) at a glance
As of Oct 20, 2026, Thermo Fisher Scientific (TMO) shares are priced at $687.37, giving the company a market cap of 251.20B, a price-to-earnings ratio of 36.55 and a dividend yield of 0.26%.
Today the stock has traded between $679.32 and $693.37. The current price is 1.2% above the day's low and 0.9% below its high.
Volume so far is 2.58M shares, in line with the average of 2.23M shares a day.
Over the past year Thermo Fisher Scientific has ranged from $435.27 to $704.00, and now sits 94% of the way up that range.
Thermo Fisher Scientific met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $6.03 per share against an estimate of $5.77.
The average analyst price target is $671.18, 2.4% below the current price, from 19 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy78.9%
- Hold21.1%
- Sell0.0%
- Low
- $559.19
- Now
- $687.37
- High
- $819.00
TMO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 2.7% on average.
- Q3 FY24: reported $5.28 per share against an estimate of $5.30
- Q4 FY24: reported $6.10 per share against an estimate of $6.00
- Q1 FY25: reported $5.15 per share against an estimate of $5.15
- Q2 FY25: reported $5.36 per share against an estimate of $5.28
- Q3 FY25: reported $5.79 per share against an estimate of $5.55
- Q4 FY25: reported $6.57 per share against an estimate of $6.51
- Q1 FY26: reported $5.44 per share against an estimate of $5.29
- Q2 FY26: reported $6.03 per share against an estimate of $5.77
TMO news
- Kaustubh Bagalkote
- Kaustubh Bagalkote
Lam Research Could Swing $28.6 Billion After Earnings
10 Health Care Stocks With Whale Alerts In Today’s Session
- Piero Cingari
The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited
- Vandana Singh
EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial
- Chandrima Sanyal
JPMorgan’s October Stock Picks Hint at 3 ETF Trades: Value, AI Power, Health Care
- Press releaseBusiness Wire
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Evette Mitkov
Thermo Fisher Stock Hits Record High: What's Happening?
Similar companies
Companies in the same industry as Thermo Fisher Scientific
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.